DI SERI, Marisa
 Distribuzione geografica
Continente #
NA - Nord America 1.328
EU - Europa 838
AS - Asia 252
SA - Sud America 12
AF - Africa 7
OC - Oceania 1
Totale 2.438
Nazione #
US - Stati Uniti d'America 1.317
DE - Germania 326
IT - Italia 119
SG - Singapore 106
SE - Svezia 105
UA - Ucraina 99
IN - India 80
RU - Federazione Russa 66
CN - Cina 58
FI - Finlandia 52
GB - Regno Unito 27
BG - Bulgaria 12
CA - Canada 10
AR - Argentina 9
BE - Belgio 7
FR - Francia 7
IE - Irlanda 7
RO - Romania 6
TG - Togo 5
ES - Italia 3
CL - Cile 2
LT - Lituania 2
TW - Taiwan 2
AU - Australia 1
BR - Brasile 1
BZ - Belize 1
EG - Egitto 1
JP - Giappone 1
LK - Sri Lanka 1
LY - Libia 1
MN - Mongolia 1
TH - Thailandia 1
TR - Turchia 1
VN - Vietnam 1
Totale 2.438
Città #
Fairfield 158
Chandler 139
Ann Arbor 98
Ashburn 70
Seattle 70
Singapore 68
Houston 65
Santa Clara 61
Woodbridge 59
Wilmington 49
Cambridge 47
Princeton 47
Jacksonville 38
Plano 38
Rome 36
Beijing 34
San Paolo di Civitate 33
Grafing 26
Millbury 24
Dearborn 23
Lawrence 22
Boston 21
Des Moines 18
Helsinki 15
Andover 13
Sofia 12
Boardman 11
Milan 11
Norwalk 10
Federal 9
New York 9
San Diego 9
Brussels 7
Moscow 7
Pune 6
Lomé 5
Dublin 4
Kunming 4
Mannheim 4
Shenyang 4
Falkenstein 3
Falls Church 3
London 3
Los Angeles 3
North York 3
Ottawa 3
Phoenix 3
Shannon 3
Toronto 3
Bremen 2
Bühl 2
Capannori 2
Foggia 2
Fremont 2
Jinan 2
Kansas City 2
Romainville 2
Southend 2
Taipei 2
Yellow Springs 2
Auburn Hills 1
Augusta 1
Aversa 1
Bangkok 1
Belize City 1
Berlin 1
Bologna 1
Buffalo 1
Caivano 1
Centrale 1
Colombo 1
Florence 1
Frankfurt am Main 1
Galbiate 1
Guangzhou 1
Gunzenhausen 1
Handan 1
Hanoi 1
Hefei 1
Istanbul 1
Leawood 1
Melbourne 1
Monmouth Junction 1
Monterotondo 1
Murcia 1
Nanjing 1
Napoli 1
Nutley 1
Piediluco 1
Portsmouth 1
Roda 1
San Mateo 1
Saratov 1
Seville 1
Shanghai 1
Simi Valley 1
Tappahannock 1
Tokyo 1
Turin 1
Ulaanbaatar 1
Totale 1.473
Nome #
LONG-TERM EXPERIENCE WITH TOTALLY IMPLANTABLE SYSTEMS(TIS)IN NEOPLASTIC PATIENTS THROUGH CEPHALIC VEIN ACCESS. 129
Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer 128
Lung cancer and skeletal muscle metastases 110
Long-term survival after lung resection for cancer in the aged 109
Surgery in Multimodal Treatment of Cancer: Peritoneal Carcinomatosis 99
What caused gastrointestinal bleeding in a woman with a history of pleural mesothelioma? Metastatic diffuse epithelioid mesothelioma. 95
Integrated multidisciplinary treatment of colorectal neoplasms 94
surgery in multimodal treatment of cancer: peritoneal carcinomatosis 92
A case of renal cell carcinoma with bone and lymph node metastases 87
Cytoreductive surgery plus intraperitoneal chemohyperthermic perfusion (IPCHP) in the treatment of advanced primary and recurrent ovarian cancer: our early experience 87
Excisional biopsy of non-palpable breast lesions: the use of an ultrasound intraoperative guide 82
Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer 82
Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 75
Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero. 73
The role of hypoxic stop-flow perfusion and high dose chemotherapy in the tratment of regionally advanced colorectal cancer 71
SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA 71
Capecitabine in elderly patients with metastatic breast cancer 70
Etoricoxib and anastrozole in adjuvant early breast cancer: ETAN trial (phase III) 65
Weekly combination of non-pegylated liposomal doxorubicin and taxane in first-line breast cancer: wALT trial (phase I-II) 65
Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US vs Sonovue low MI real time enhanced US as compared with MDCT or Gd-BOPTA MRI 61
Colorectal cancer and anemia: new prospectives of treatment 54
Il carcinoma del colon retto metastatico- Sicurezza ed efficiacia di Panitumumab dopo reazioni infusionali da Cetuximab nel carcinoma del colon retto metastatico 52
Relationship between Octreoscan findings and cold Somatostatin-analogue therapy effectiveness in patients with advanced androgen deprivation refractory prostate cancer 51
Biosimilar filgrastim in routine clinical practice: a single centre experience. 50
Usefulness of the determination of 5NU together with CA 19-9 in the diagnosis and monitoring of dyskaryokinetic liver diseases 42
WALT TRIAL (PHASE III): WEEKLY NON PEGYLATED LIPOSOMAL ANTHRACYCLINE AND TAXANE COMBINATION IN FIRSTLINE BREAST CANCER CHEMOTHERAPY 42
TOXICITY OF WEEKLY LIPOSOMAL DOXORUBICIN AND PACLITAXEL IN METASTATIC BREAST CANCER (MBC): 24 MONTHS UPDATE 41
Anaemia and erythropoietic growth factors supportive treatments in colorectal cancer 39
Identification of families selected for breast cancer predisposition risk and showing low rate of BRCA1/BRCA2 mutations (< 10%) 39
Start-therapy in cancer pain management: news from the past 39
Tolerability of raltitrexed ('Tomudex') in elderly patients with colorectal cancer 39
Anemia As A Predictive Factor In Colorectal Cancer (CRC) Patients (PTS) 35
Safety, Tollerability and Early Response Evaluation of Sorafenib In Hepatocellular Carcinoma In Elderly: Use of Contrast-enhanced Ultrasonography (ce-us) 34
Long-term maintenance bacille Calmette-Guérin therapy in high-grade superficial bladder cancer 34
LONG TERM MAINTENANCE BACILLE CALMETTE-GUERRIN THERAPY IN HIGH GRADE BLADDER CANCER. 33
UTILITY OF MANTEINANCE INTRAVESCICAL IMMUNOTHERAPY IN PREVENTING RECURRENCE AND PROGRESSION OF SUPERFICIAL BLADDER CANCER 30
Incidence of Lipid and Bone Metabolism Imbalance In Postmenopausal Women Treated With 5 Years Tamoxifen (tam) Or Aromatase Inhibitor (ai) After Tamoxifene Withdrawal 27
Phase II study evaluating the activity and toxicity of biweekly schedule of gemcitabine and paclitaxel in anthracycline-pretratted breast cancer 20
BIS ETORICOXIB AND ANASTROZOL: NEW FRONTIERS IN. BREAST CANCER TARGET THERAPY? 19
null 19
Totale 2.484
Categoria #
all - tutte 7.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.078


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020248 0 0 0 0 0 0 59 56 48 46 33 6
2020/2021171 15 26 4 12 6 14 2 18 18 39 15 2
2021/2022382 2 15 21 15 52 12 9 37 28 37 68 86
2022/2023468 86 93 41 38 55 64 5 19 55 1 11 0
2023/2024183 13 40 3 15 18 34 0 11 1 13 20 15
2024/2025187 17 13 23 9 81 44 0 0 0 0 0 0
Totale 2.484